Neurologists at Jerusalem's Hadassah-University Hospital, Ein Kerem, are the first in the world to help multiple sclerosis (MS) and amyotropic lateral sclerosis (ALS) patients by injecting their spinal columns with large numbers of adult stem cells taken from their bone marrow and multiplied in culture. The clinical trial, while "encouraging" and "promising," remains highly experimental, as all the patients have undergone a single injection with no untreated control group for comparison. With the first patients having received it two years ago, it is too early to know how successful it will be in the long term. Prof. Dimitrios Karousis, a...